Disturbances of the expression of metalloproteinases and their tissue inhibitors cause destruction of the basement membrane in pemphigoid

Polish Journal of Pathology

Volumn 57, Issue 2, 2006, Pages 71-76

  Narbutt, Joanna ^a   Waszczykowska, Elzbieta ^a   Lukamowicz, Jolanta ^b   Sysa Jȩdrzejowska, Anna ^a   Kobos, Józef ^a   Zebrowska, Agnieszka ^a,c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^c NONE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; BLISTER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LOCALIZATION; EPIDERMIS CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; KERATINOCYTE; MAJOR CLINICAL STUDY; MALE; PEMPHIGOID; PROTEIN EXPRESSION; SKIN BIOPSY;

EID: 33749013302     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Aeschliman D, Kaupp O, Paulsson M: Osteonectin is a major glutaminyl substrate for transglutaminase-catalyzed cross-linking in cartilage matrix. J Cell Biol 1995, 129, 881-892.
2. Cerretti DP, Poindexter K, Castner BJ et al: Characterisation of the cDNA and gene for mouse TNF alpha converting enzyme (TACE/ADAM) and its location to mouse chromosome 12 and human chromosome 2p25. Cytokine 1999, 11, 541-551.
3. Dietrich W, Ehnis T, Bauer M et al: Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Med 1997, 3, 797-801.
4. Dietrich W, Laag E, Bruckner-Tuderman L et al: Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol 1999, 113, 133-136.
5. Grando SA, Glukhenky BT, Orannik GN et al: Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid. Arch Dermatol 1989, 125, 925-930.
6. Jordan RE: Basement zone antibodies in bullous pemphigoid. JAMA 1967, 200, 751-756.
7. Kuno K: Molecular cloning of gene encoding a new type of metalloproteinases - disintegrin family protein with trombospondin motifs as an inflammation associated gene. J Biol Chem 1998, 272, 556-562.
8. Martinez J, Chalupowicz R, Roush A: Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry 1994, 33, 2538-2545.
9. Nikkcola J, Vihinen P, Vuoristo MS, Kettohunpu-Lehtinen P, Kahari VM, Pyrhonen S: High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin Cancer Res 2005, 11, 5158-5166.
10. Oikarinen A, Kyimaniemi M, Autjo-Harmainen H et al: Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, inducting during re-epithelialization and decrease by topical glucocorticosteroids. J Invest Dermatol 1993, 101, 205-210.
11. Oikarinen AI, Reunala T, Zone JJ et al: Proteolytic enzymes in blister fluids from patients with dermatitis herpetiformis. Br J Dermatol 1986, 114, 295-230.
12. Pauschinger M, Chandrasekharan K, Li J et al: Mechanisms of extracellular matrix remodeling in dilated cardiomiopathy. Herz 2002, 27, 677-682.
13. Primakoff P, Myles DG: The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet 2000, 16, 83-87.
14. Ruokolainen H, Paakko P, Turpeenniemi-Hujanen T: Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker. Int J Cancer 2005, 1, 116, 422-427.
15. Sardy M, Karpati S, Merkl B et al: Epidermal transglutaminase (Tgase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002, 195, 747-757.
16. Schmidt E, Obe K, Brecker EB et al: Serum levels of autoantibodies to BP 180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 2000, 136, 253-254.
17. Schmidt E, Reimer S, Kruse N et al: Autoantibodies to BP 180 associated with bullous pemphigoid relase interleukin-6 and interleukin-8 from cultured human keratinocytes. J Invest Dermatol 2000, 115, 842-848.
18. Stanley JR: Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv Immunol 1992, 53, 291-325.
19. Stone AI, Kroeger M, Xiang Q et al: Structure- function analysis of the ADAm family of disintegrin - like and metalloproteinase-containing proteins. J Protein Chem 2000, 18, 447-465.
20. Stricklin GP, Nanney LB: Immunolocalization of collagenase and TIMPs in healing human burn wounds. J Invest Dermatol 1994, 103, 488-492.
21. Verraes S, Homebeck W, Polette M et al: Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP 180 (type XVII) in human bullous pemphigoid. J Invest Dermatol 2001, 117, 1091-1096.